Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass
- 31 August 1994
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 58 (2) , 472-477
- https://doi.org/10.1016/0003-4975(94)92231-4
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Assessment of the Neutrophil Dominating Protein Calprotectin in Feces: A Methodologic StudyScandinavian Journal of Gastroenterology, 1992
- Clinical application of heparin-coated perfusion equipment with special emphasis on patients refusing homologous transfusionsPerfusion, 1991
- Biocompatibility of extracorporeal circulationThe Journal of Thoracic and Cardiovascular Surgery, 1991
- Fluid phase generation of terminal complement complex as a novel index of bioincompatibilityKidney International, 1990
- Analysis of serial measurements in medical research.BMJ, 1990
- The Effects of Complement Activation During Cardiopulmonary BypassAnnals of Surgery, 1988
- Quantification in Enzyme‐Linked Immunosorbent Assay of a C3 Neoepitope Expressed on Activated Human Complement Factor C3Scandinavian Journal of Immunology, 1988
- Quantification of the Terminal Complement Complex in Human Plasma by an Enzyme‐Linked Immunosorbent Assay Based on Monoclonal Antibodies against a Neoantigen of the ComplexScandinavian Journal of Immunology, 1985
- A New Non-Thrombogenic Surface Prepared by Selective Covalent Binding of Heparin Via a Modified Reducing Terminal ResidueBiomaterials, Medical Devices, and Artificial Organs, 1983
- Effects of Serum and Cations on the Selective Release of Granular Proteins from Human Neutrophils during PhagocytosisScandinavian Journal of Haematology, 1979